Comparison of BiomeOne and PD-L1 expression tests as a predictor for response to immune checkpoint inhibitors (ICI) in patients with non-small cell lung cancer (NSCLC)

被引：1
|
作者：
Robinson, I. [1 ]
Hochmair, M. J. [1 ]
Ay, L. [1 ]
Absenger, G. [2 ]
Jansen, C. [3 ]
Pacifico, C. [3 ]
Sladek, B. [3 ]
Knabl, A. [3 ]
Gasche, N. [3 ]
Valipour, A. [1 ]
机构：
[1] Karl Landsteiner Inst Lung Res & Pulm Oncol, Vienna, Austria
[2] Graz Univ Klin Innere Med, LKH Univ Klinikum, Graz, Austria
[3] Biome Diagnost GmbH, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 08期
关键词：
D O I：
10.1016/j.annonc.2022.09.056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
55P
引用
收藏
页码：S1400 / S1400
页数：1
相关论文
共 50 条
  • [31] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430
  • [32] Comparative study of two PD-L1 expression assays in patients with non-small cell lung cancer (NSCLC).
    Feng, Zheng
    Schlichting, Michael
    Helwig, Christoph
    Chand, Vikram K.
    Gelb, Arnold
    Jin, Hulin
    Grote, Hans Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [33] PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)
    Angelicola, Stefania
    Giunchi, Francesca
    Ruzzi, Francesca
    Frascino, Mariateresa
    Pitzalis, Mary
    Scalambra, Laura
    Semprini, Maria Sofia
    Pittino, Olga Maria
    Cappello, Chiara
    Siracusa, Irene
    Chillico, Ilaria Candida
    Di Noia, Martina
    Turato, Cristian
    De Siervi, Silvia
    Lescai, Francesco
    Ciavattini, Teresa
    Lopatriello, Giulia
    Bertoli, Luca
    De Jonge, Hugo
    Iamele, Luisa
    Altimari, Annalisa
    Gruppioni, Elisa
    Ardizzoni, Andrea
    Rossato, Marzia
    Gelsomino, Francesco
    Lollini, Pier-Luigi
    Palladini, Arianna
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [34] Resistance to PD-1/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancer
    Li, Lijun
    Pu, Haihong
    Zhang, Xiaoxin
    Guo, Xiaotian
    Li, Guangrui
    Zhang, Minghui
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 209
  • [35] PTPRD/PTPRT mutations as potential positive predictor for response of immune checkpoint inhibitors in non-small cell lung cancer (NSCLC).
    Zeng, Jian
    Wang, Guoqiang
    Yan, Zhengqing
    Zheng, Hao
    Li, Jianqiang
    Tao, Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Chronic immune checkpoint inhibitor (ICI) pneumonitis in patients (pts) with non-small cell lung cancer (NSCLC).
    Stuart, Jessica
    Ricciuti, Biagio
    Alessi, Joao Victor Machado
    Nishino, Mizuki
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Hersom, Maria
    Jorgensen, Jan T.
    THERAPEUTIC DRUG MONITORING, 2018, 40 (01) : 9 - 16
  • [38] Comparison of PD-L1 mRNA Expression Measured with the CheckPoint Typer® Assay with PD-L1 Protein Expression Assessed with Immunohistochemistry in Non-small Cell Lung Cancer
    Erber, Ramona
    Stoehr, Robert
    Herlein, Stefanie
    Giedl, Claudia
    Rieker, Ralf Joachim
    Fuchs, Florian
    Ficker, Joachim H.
    Hartmann, Arndt
    Veltrup, Elke
    Wirtz, Ralph M.
    Brueckl, Wolfgang M.
    ANTICANCER RESEARCH, 2017, 37 (12) : 6771 - 6778
  • [39] Letter comments on: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression
    Leonetti, Alessandro
    Giudice, Giulia C.
    Perrone, Fabiana
    Tiseo, Marcello
    Giovannetti, Elisa
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 520 - 522
  • [40] Quantification of PD-L1 expression in non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S402 - S404
12345